GlycoEra is developing biologics to selectively degrade autoimmune disease causing circulating proteins rapidly, selectively, and deeply while avoiding broader dampening of the immune system. This offers many potential benefits over existing broad-spectrum immune-suppressing therapies.
- https://glycoera.com/
- +41 44 244 95 95
- Send an email
- Dominique Nicolas Sirena